Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |